Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

<p>Kaplan-Meier curves of overall survival of patients with long-term response (LTR), short-term response (STR), and progressive disease (PD) from individual sites.</p>

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखक: Rohit Thummalapalli (17314483) (author)
अन्य लेखक: Biagio Ricciuti (14951247) (author), Chaitanya Bandlamudi (15047205) (author), Daniel Muldoon (17314486) (author), Hira Rizvi (16547594) (author), Arielle Elkrief (15055750) (author), Jia Luo (15034764) (author), Joao V. Alessi (17314489) (author), Federica Pecci (15561470) (author), Giuseppe Lamberti (15024714) (author), Alessandro Di Federico (15561473) (author), Lingzhi Hong (17314492) (author), Jianjun Zhang (16041833) (author), John V. Heymach (14934698) (author), Don L. Gibbons (15055721) (author), Andrew J. Plodkowski (15028415) (author), Vignesh Ravichandran (15052350) (author), Mark T.A. Donoghue (15054209) (author), Chad Vanderbilt (15050973) (author), Marc Ladanyi (15050661) (author), Charles M. Rudin (11572933) (author), Mark G. Kris (15055774) (author), Gregory J. Riely (14961725) (author), Jamie E. Chaft (14937195) (author), Matthew D. Hellmann (14937198) (author), Natalie I. Vokes (17314495) (author), Mark M. Awad (14961722) (author), Adam J. Schoenfeld (15022025) (author)
प्रकाशित: 2025
विषय:
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
_version_ 1849927631388016640
author Rohit Thummalapalli (17314483)
author2 Biagio Ricciuti (14951247)
Chaitanya Bandlamudi (15047205)
Daniel Muldoon (17314486)
Hira Rizvi (16547594)
Arielle Elkrief (15055750)
Jia Luo (15034764)
Joao V. Alessi (17314489)
Federica Pecci (15561470)
Giuseppe Lamberti (15024714)
Alessandro Di Federico (15561473)
Lingzhi Hong (17314492)
Jianjun Zhang (16041833)
John V. Heymach (14934698)
Don L. Gibbons (15055721)
Andrew J. Plodkowski (15028415)
Vignesh Ravichandran (15052350)
Mark T.A. Donoghue (15054209)
Chad Vanderbilt (15050973)
Marc Ladanyi (15050661)
Charles M. Rudin (11572933)
Mark G. Kris (15055774)
Gregory J. Riely (14961725)
Jamie E. Chaft (14937195)
Matthew D. Hellmann (14937198)
Natalie I. Vokes (17314495)
Mark M. Awad (14961722)
Adam J. Schoenfeld (15022025)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Rohit Thummalapalli (17314483)
Biagio Ricciuti (14951247)
Chaitanya Bandlamudi (15047205)
Daniel Muldoon (17314486)
Hira Rizvi (16547594)
Arielle Elkrief (15055750)
Jia Luo (15034764)
Joao V. Alessi (17314489)
Federica Pecci (15561470)
Giuseppe Lamberti (15024714)
Alessandro Di Federico (15561473)
Lingzhi Hong (17314492)
Jianjun Zhang (16041833)
John V. Heymach (14934698)
Don L. Gibbons (15055721)
Andrew J. Plodkowski (15028415)
Vignesh Ravichandran (15052350)
Mark T.A. Donoghue (15054209)
Chad Vanderbilt (15050973)
Marc Ladanyi (15050661)
Charles M. Rudin (11572933)
Mark G. Kris (15055774)
Gregory J. Riely (14961725)
Jamie E. Chaft (14937195)
Matthew D. Hellmann (14937198)
Natalie I. Vokes (17314495)
Mark M. Awad (14961722)
Adam J. Schoenfeld (15022025)
author_role author
dc.creator.none.fl_str_mv Rohit Thummalapalli (17314483)
Biagio Ricciuti (14951247)
Chaitanya Bandlamudi (15047205)
Daniel Muldoon (17314486)
Hira Rizvi (16547594)
Arielle Elkrief (15055750)
Jia Luo (15034764)
Joao V. Alessi (17314489)
Federica Pecci (15561470)
Giuseppe Lamberti (15024714)
Alessandro Di Federico (15561473)
Lingzhi Hong (17314492)
Jianjun Zhang (16041833)
John V. Heymach (14934698)
Don L. Gibbons (15055721)
Andrew J. Plodkowski (15028415)
Vignesh Ravichandran (15052350)
Mark T.A. Donoghue (15054209)
Chad Vanderbilt (15050973)
Marc Ladanyi (15050661)
Charles M. Rudin (11572933)
Mark G. Kris (15055774)
Gregory J. Riely (14961725)
Jamie E. Chaft (14937195)
Matthew D. Hellmann (14937198)
Natalie I. Vokes (17314495)
Mark M. Awad (14961722)
Adam J. Schoenfeld (15022025)
dc.date.none.fl_str_mv 2025-11-25T13:44:50Z
dc.identifier.none.fl_str_mv 10.1158/1078-0432.30710440
dc.relation.none.fl_str_mv https://figshare.com/articles/figure/Supplementary_Figure_S3_from_Clinical_and_Molecular_Features_of_Long-term_Response_to_Immune_Checkpoint_Inhibitors_in_Patients_with_Advanced_Non_Small_Cell_Lung_Cancer/30710440
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Cancer Detection and Diagnosis
Immuno-oncology
Clinical Research and Trials
Biomarkers
Prognostic biomarkers
Immunotherapy
Biomarkers for immunotherapy
Checkpoint blockade
Lung Cancer
Precision Medicine
dc.title.none.fl_str_mv Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
dc.type.none.fl_str_mv Image
Figure
info:eu-repo/semantics/publishedVersion
image
description <p>Kaplan-Meier curves of overall survival of patients with long-term response (LTR), short-term response (STR), and progressive disease (PD) from individual sites.</p>
eu_rights_str_mv openAccess
id Manara_14396e7d9ac6f32a17ff98b735af7bdf
identifier_str_mv 10.1158/1078-0432.30710440
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30710440
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung CancerRohit Thummalapalli (17314483)Biagio Ricciuti (14951247)Chaitanya Bandlamudi (15047205)Daniel Muldoon (17314486)Hira Rizvi (16547594)Arielle Elkrief (15055750)Jia Luo (15034764)Joao V. Alessi (17314489)Federica Pecci (15561470)Giuseppe Lamberti (15024714)Alessandro Di Federico (15561473)Lingzhi Hong (17314492)Jianjun Zhang (16041833)John V. Heymach (14934698)Don L. Gibbons (15055721)Andrew J. Plodkowski (15028415)Vignesh Ravichandran (15052350)Mark T.A. Donoghue (15054209)Chad Vanderbilt (15050973)Marc Ladanyi (15050661)Charles M. Rudin (11572933)Mark G. Kris (15055774)Gregory J. Riely (14961725)Jamie E. Chaft (14937195)Matthew D. Hellmann (14937198)Natalie I. Vokes (17314495)Mark M. Awad (14961722)Adam J. Schoenfeld (15022025)CancerCancer Detection and DiagnosisImmuno-oncologyClinical Research and TrialsBiomarkersPrognostic biomarkersImmunotherapyBiomarkers for immunotherapyCheckpoint blockadeLung CancerPrecision Medicine<p>Kaplan-Meier curves of overall survival of patients with long-term response (LTR), short-term response (STR), and progressive disease (PD) from individual sites.</p>2025-11-25T13:44:50ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30710440https://figshare.com/articles/figure/Supplementary_Figure_S3_from_Clinical_and_Molecular_Features_of_Long-term_Response_to_Immune_Checkpoint_Inhibitors_in_Patients_with_Advanced_Non_Small_Cell_Lung_Cancer/30710440CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307104402025-11-25T13:44:50Z
spellingShingle Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
Rohit Thummalapalli (17314483)
Cancer
Cancer Detection and Diagnosis
Immuno-oncology
Clinical Research and Trials
Biomarkers
Prognostic biomarkers
Immunotherapy
Biomarkers for immunotherapy
Checkpoint blockade
Lung Cancer
Precision Medicine
status_str publishedVersion
title Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
title_full Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
title_fullStr Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
title_full_unstemmed Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
title_short Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
title_sort Supplementary Figure S3 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
topic Cancer
Cancer Detection and Diagnosis
Immuno-oncology
Clinical Research and Trials
Biomarkers
Prognostic biomarkers
Immunotherapy
Biomarkers for immunotherapy
Checkpoint blockade
Lung Cancer
Precision Medicine